Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05223374Completed

Extension for Community Healthcare Outcomes (ECHO) Autism Diagnostic Study in Primary Care Setting

Role: lead

NCT03871179Not ApplicableWithdrawn

Cognoa ASD Diagnostic Device - Data Collection Study

Role: lead

NCT04326231Not ApplicableTerminated

Cognoa Autism Spectrum Disorder (ASD) Digital Therapeutic Engagement and Usability Study

Role: lead

NCT04151290Not ApplicableCompleted

Cognoa ASD Diagnosis Aid Validation Study

Role: lead

All 4 trials loaded